Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients

Sa1274 Efficacy and Safety of Vedolizumab With Advancing Age in Patients With Ulcerative Colitis: Results From the GEMINI 1 Study

(2015) Vijay Yajnik et al.   GASTROENTEROLOGY

Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis

(2015) Mahmoud H. Mosli et al.   INFLAMMATORY BOWEL DISEASES

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

(2014) Bruce E. Sands et al.   GASTROENTEROLOGY

P497 Efficacy of continued vedolizumab therapy in patients with Crohn's disease who did not respond to vedolizumab induction therapy at week 6

(2014) W.J. Sandborn et al.   Journal of Crohns & Colitis

Inflammatory Bowel Disease

(2013)   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A Korean multicenter retrospective study

(2013) Kang-Moon Lee et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2013) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibition of Leukocyte Trafficking in Inflammatory Bowel Disease

(2013) Fabio Cominelli   NEW ENGLAND JOURNAL OF MEDICINE

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

(2013) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease

(2012) P. S. A. Silva et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

(2012) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

(2012) Christina Ha et al.   Clinical Gastroenterology and Hepatology

Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome

(2012) Orlando García-Bosch et al.   Journal of Crohns & Colitis

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

(2011) Jean Frédéric Colombel et al.   GASTROENTEROLOGY

Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab

(2010) C. Taxonera et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

(2010) Matthieu Allez et al.   Journal of Crohns & Colitis

Long-term outcome after infliximab for refractory ulcerative colitis

(2008) Marc Ferrante et al.   Journal of Crohns & Colitis